UK biotech OMass raises £27.5m for GPCR drug discoveryOxford, UK-based OMass Therapeutics has extended its first-round financing to more than £41 million ($53 million), to help Share XUK biotech OMass raises £27.5m for GPCR drug discoveryhttps://pharmaphorum.com/news/uk-biotech-omass-raises-27-5m-for-gpcr-drug-discovery/
Sosei Heptares bags another big partnership, this time with TakedaJapanese biotech Sosei’s buyout of the UK’s Heptares four years ago has rewarded it with a string of Share XSosei Heptares bags another big partnership, this time with Takedahttps://pharmaphorum.com/news/sosei-heptares-bags-another-big-partnership-this-time-with-takeda/
Pfizer selects first GPCR candidate from Sosei Heptares tie-upPfizer has selected the first drug candidate from a collaboration with Sosei Group to develop drugs for major Share XPfizer selects first GPCR candidate from Sosei Heptares tie-uphttps://pharmaphorum.com/news/pfizer-selects-first-gpcr-candidate-from-sosei-heptares-tie-up/
